An unexpected bonus

Blocking STAT3 could help cancer patients in 2 ways

2014-10-10

(Press-News.org) The so-called Signal Transducers and Activators of Transcription, or STATs, are key components of many different signalling pathways. Not surprisingly, then, when something goes wrong with their regulation the consequences can be severe and many types of cancer are known to be associated with increased activities of one or more STAT protein. STAT3 is a frequent culprit and is often found to be activated in tumour cells.

Considerable efforts are going into developing inhibitors of STAT3 for use in cancer therapy but it is unclear whether these will turn out to be suitable for use in patients.

The problem is that STAT3 is not all bad but has a number of crucial functions in the healthy body. In particular it is important for the development of several kinds of cells of the immune system. The intriguingly named Natural Killer (NK) cells represent the first line of defence against viruses and cancer, to which they react by producing a range of proteins that attack the infected cells. It is important to investigate how this key component of the body's own anti-cancer defence mechanisms might respond to the inactivation of STAT3.

The issue has been tackled by Dagmar Gotthardt and colleagues in the Institute of Pharmacology and Toxicology of the University of Veterinary Medicine, Vienna (Vetmeduni Vienna). Surprisingly, the loss of STAT3 in NK cells of the mouse led not to a decrease but to an increase in killing activity against melanoma cells and leukaemia cells. The decrease in metastasis caused by melanoma cells was especially dramatic and confirmed that NK cells lacking STAT3 are extremely efficient killers of tumour cells.

Gotthardt is naturally excited by the finding. As she says, "we were expecting the loss of STAT3 to make the NK cells less efficient. Instead it makes them even more potent killers. Inhibiting STAT3 could thus help cancer patients in two ways, both stopping the cancer cells from dividing and helping the patients' NK cells to fight them more efficiently."

INFORMATION: The article "Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance", by Dagmar Gotthardt, Eva M. Putz, Elisabeth Straka, Petra Kudweis, Mario Baggio, Valeria Poli, Birgit Strobl, Mathias Müller and Veronika Sexl was published online on the 9th of October in the journal Blood. DOI: http://dx.doi.org/10.1182/blood-2014-03-564450

About the University of Veterinary Medicine, Vienna

The University of Veterinary Medicine, Vienna in Austria is one of the leading academic and research institutions in the field of Veterinary Sciences in Europe. About 1,300 employees and 2,300 students work on the campus in the north of Vienna which also houses five university clinics and various research sites. Outside of Vienna the university operates Teaching and Research Farms. http://www.vetmeduni.ac.at

Scientific Contact: Prof. Veronika Sexl
Institute of Pharmacology and Toxicology
University of Veterinary Medicine Vienna (Vetmeduni Vienna)
T +43 1 25077-2910
veronika.sexl@vetmeduni.ac.at

or

Dagmar Gotthardt
Institute of Pharmacology and Toxicology
University of Veterinary Medicine Vienna (Vetmeduni Vienna)
T +43 1 25077-2900
dagmar.gotthardt@vetmeduni.ac.at

Released by: Susanna Kautschitsch
Science Communication / Public Relations
University of Veterinary Medicine Vienna (Vetmeduni Vienna)
T +43 1 25077-1153
susanna.kautschitsch@vetmeduni.ac.at

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Professor examines terrorist propaganda

2014-10-10

New research out of Queen's University could give insight into what terrorists are thinking. Professor David Skillicorn (School of Computing) analyzed language used in two jihadist magazines to gain intelligence about terrorist strategy. He examined the language used in Inspire, an online magazine reportedly published by al-Qaida in the Arabian Peninsula, which aims to increase the availability of their message, and the Islamic State News published by ISIS. Inspire has attracted attention because of its goal of attracting lone-wolf attacks in Western countries. "The payoff ...

Fingolimod in new therapeutic indication: Added benefit not proven

2014-10-10

The immunosuppressive drug fingolimod (trade name: Gilenya) was approved for an expanded therapeutic indication in May 2014: It is now also available for adults with highly active relapsing remitting multiple sclerosis (RRMS) who had received other pretreatment than interferon beta (IFN-β). In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether the drug offers an added benefit over the appropriate comparator therapy in this ...

Mechanism that repairs brain after stroke discovered

2014-10-10

A previously unknown mechanism through which the brain produces new nerve cells after a stroke has been discovered at Lund University and Karolinska Institute in Sweden. The findings have been published in the journal SCIENCE. A stroke is caused by a blood clot blocking a blood vessel in the brain, which leads to an interruption of blood flow and therefore a shortage of oxygen. Many nerve cells die, resulting in motor, sensory and cognitive problems. The researchers have shown that following an induced stroke in mice, support cells, so-called astrocytes, start to form ...

New technique enables increasingly accurate PET scan to detect cancer and heart conditions

2014-10-10

A novel technique which reduces image degradation caused by respiratory motion during a PET scan was developed in a recent study at the University of Eastern Finland. PET scanning is routinely used to detect cancer and heart conditions. The new technique presented in the PhD thesis of Tuomas Koivumäki, MSc (Tech.), is based on bioimpedance measurement and it allows for image reconstruction at a specific phase of the patient's breathing pattern. This, in turn, makes it possible to reduce image degradation caused by motion. In the future, the newly developed technique ...

LSU Health tumor registry data find acadiana colon cancer rates among nation's highest

2014-10-10

New Orleans, LA – A special study using data from LSU Health New Orleans School of Public Health's Louisiana Tumor Registry has found that colorectal cancer incidence rates in the Louisiana Acadian parishes are among the highest in the United States. This study appears to be the first to identify a high rate of cancer in a large, regional, US founder population, raising the possibility of a genetic predisposition. Alternatively, an unidentified, robust environmental risk factor may be present. The paper is published online in Clinical and Translational Gastroenterology, ...

An enzyme and synaptic plasticity

2014-10-10

A small, "empty" space teeming with activity: a synapse is a complex structure where the neural (electrical) signal from the presynaptic neuron, as it travels towards its target –a muscle, a gland or another neuron – turns into a chemical signal capable of crossing the synaptic space before becoming electrical again once on the other side. A synapse is a "dynamic" space not only because of the endless work that goes on there, but also for its ability to change its action over time (synaptic plasticity) as a result of either normal physiological processes (e.g., ...

The Lancet Global Health: Widely used sanitation programs do not necessarily improve health

2014-10-10

The sanitation intervention delivered under the terms of the Government of India's Total Sanitation Campaign—the world's largest sanitation initiative—provided almost 25 000 individuals in rural India with access to a latrine. However, it did not reduce exposure to faecal pathogens or decrease the occurrence of diarrhoea, parasitic worm infections, or child malnutrition. "The programme is effective in building latrines, but not all households participate"*, explains lead author Professor Thomas Clasen from Emory University, Atlanta, USA and the London School ...

University of Maryland School of Medicine begins Ebola vaccine trials in Mali

2014-10-10

VIDEO: Dr. Myron M. Levine, Director of the Center for Vaccine Development at the University of Maryland School of Medicine describes the Ebola vaccine testing taking place in Mali, West Africa. Click here for more information. Professor Myron M. Levine, MD, Director of the Center for Vaccine Development (CVD) at the University of Maryland School of Medicine (UM SOM), and UM SOM Dean E. Albert Reece MD, PhD, MBA, announced today that the CVD, in conjunction with its sister institution, ...

TSRI scientists create mimic of 'good' cholesterol to fight heart disease and stroke

2014-10-10

LA JOLLA, CA – October 9, 2013 - Scientists at The Scripps Research Institute (TSRI) have created a synthetic molecule that mimics "good" cholesterol and have shown it can reduce plaque buildup in the arteries of animal models. The molecule, taken orally, improved cholesterol in just two weeks. This research, published in the October issue of Journal of Lipid Research, points scientists toward a new method for treating atherosclerosis, a condition where plaque buildup in the arteries can cause heart attacks and strokes. "Atherosclerosis is the number one killer ...

Fish moving poleward at rate of 26 kilometers per decade

2014-10-10

Large numbers of fish will disappear from the tropics by 2050, finds a new University of Britsh Columbia study that examined the impact of climate change on fish stocks. The study identified ocean hotspots for local fish extinction but also found that changing temperatures will drive more fish into the Arctic and Antarctic waters. Using the same climate change scenarios as the Intergovernmental Panel on Climate Change, researchers projected a large-scale shift of marine fish and invertebrates. In the worst-case scenario, where the Earth's oceans warm by three degrees ...

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

An unexpected bonus

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: